Compound index

Growth Hormone Secretagogues & GHRH Analogs

Modified GRF (1–29)

Also known as Modified GRF 1–29

Cell/lab studies onlyNot approved for human use in the US

Last reviewed: 2026-11-19

Evidence status & limitations

Human results from CJC-1295 with DAC cannot be transferred to this different molecule; exact-identity human evidence remains limited.

Regulatory status

No FDA-approved human medicine for this exact identity was established in this review. Investigational research is not approval.

    Status as of 2026-11-19. Regulations change. Check FDA.gov for current information.

    WADA prohibited status: current list and context

    Known risks & open questions

    Long-term safety and reliable adverse-event rates are not established.

    Key sources

    Primary-reference and editorial check: November 19, 2026. Not an exhaustive clinical review; exact formulations and populations matter.

    Related compounds

    • CJC-1295

      Same target family · A 29-amino-acid chain. · Early human trials

    • Examorelin

      Same scientific class · A 6-amino-acid chain. · Early human trials

    • Ipamorelin

      Same scientific class · A 5-amino-acid chain. · Early human trials

    • Pralmorelin

      Same scientific class · A 6-amino-acid chain. · Early human trials

    • Sermorelin

      Same target family · A 29-amino-acid chain. · Late-stage human trials

    Related glossary terms